<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03910062</url>
  </required_header>
  <id_info>
    <org_study_id>PSS2018/MIRECMO-KOSZUTSKI/YB</org_study_id>
    <nct_id>NCT03910062</nct_id>
  </id_info>
  <brief_title>Lower Limb Surveillance During VA-ECLS</brief_title>
  <official_title>Lower Limb Surveillance During VA-ECLS: Evaluation of Angiography Through the Reperfusion Cannula at VA-ECMO Implantation and of Near Infrared Spectroscopy (NIRS) Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Temporary cardiac support by VA-ECLS can lead to lower limb ischemia. The aim of this study
      is to evaluate a multi-modal strategy (physical examination, NIRS monitoring and angiography
      through the reperfusion canula) of lower limb surveillance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      VA ECLS is used as a temporary circulatory support during cardiogenic shock and refractory
      cardiac arrest. Complications of VA ECLS include hemorrhagic, infectious and ischemic events.
      VA ECLS requires arterial and venous canules which are frequently positioned in the femoral
      artery and vein, which carries the risk of lower limb ischemia due to retrograde flow and
      obstruction of the femoral artery lumen. VA ischemia during VA ECLS is frequent (11-52%) and
      requires the use of reperfusion canula in the femoral common artery on VA ECLS implantation
      in a primary prevention strategy, before lower limb ischemia occurs. Even with this strategy,
      lower limb ischemia can occur due to arterial thrombosis, arterial spasm or insufficient
      blood flow through the reperfusion canula. Lower limb complications are prevented by
      monitoring of regional oxygen saturation, control of the reperfusion canula position
      (ultrasound, angiography) and rapid management when lower limb ischemia is suspected. There
      are no clear recommendations regarding prevention of lower limb complications during VA ECLS
      and arterial angiography has been described to diagnose ischemic events and evaluate the
      effectiveness of an intervention such as injection of vasodilators. This study is a
      prospective evaluation of a strategy to prevent lower limb complications during VA ECLS with
      a systematic arterial angiography on VA ECLS implantation and when lower limb ischemia is
      suspected (regional oxygen tissue saturation &lt;50% or a differential &gt;15% between both lower
      limbs) in addition to continuous NIRS monitoring of lower limbs during VA ECLS.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Severe limb ischemia</measure>
    <time_frame>60 days</time_frame>
    <description>Ischemia leading to surgical intervention, functional sequelae, necrosis of the extremities or compartment syndrome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days and 60 days</time_frame>
    <description>Mortality rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of ischemia of the lower limb during ICU stay</measure>
    <time_frame>2 months</time_frame>
    <description>StO2 &lt; 50% during 4 consecutive minutes AND/OR StO2 differential &gt; 15% during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of renal replacement therapy during ICU stay</measure>
    <time_frame>2 months</time_frame>
    <description>Number of patients who underwent renal replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>60 days</time_frame>
    <description>Number of days in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>60 days</time_frame>
    <description>Number of days in the hospital</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cardiogenic Shock</condition>
  <condition>Cardiac Arrest</condition>
  <condition>Lower Limb Ischemia</condition>
  <arm_group>
    <arm_group_label>VA ECMO</arm_group_label>
    <description>Patients under VA-ECMO with a femoral reperfusion cannula.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lower limb angiography via the reperfusion cannula and NIRS monitoring</intervention_name>
    <description>Data collection only (lower limb angiography, lower limbs NIRS values).</description>
    <arm_group_label>VA ECMO</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients under Temporary Cardiac Support with VA-ECLS
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Temporary circulatory support with VA ECLS

          -  Age &gt; 18 years

        Exclusion Criteria:

          -  Pregnancy

          -  History of iodinated contrast allergy

          -  History of lower limb amputation above the ankle

          -  Lower limb ischemia before starting of VA-ECLS

          -  Femoro-axillary VA-ECLS

          -  Absence of the lower limb reperfusion canula
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthieu Koszutski, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthieu Koszutski, Dr</last_name>
    <phone>+33383153017</phone>
    <email>m.koszutski@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthieu Koszutski, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>April 8, 2019</study_first_submitted>
  <study_first_submitted_qc>April 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2019</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VA-ECMO</keyword>
  <keyword>VA-ECLS</keyword>
  <keyword>Near-Infrared Spectroscopy (NIRS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Cardiogenic</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

